Deep Health AI India Limited

Operates a small pharmaceutical business alongside a residual jewellery trade, with FY26 revenue of Rs. 4.25 crore and a reported EBITDA margin of 42.4 percent. The company, formerly Deep Diamond India Limited, has shifted focus toward health, agro-tourism and investments, and is classified in the Gems, Jewellery and Watches basic industry. A Pharmaceutical Business segment generated Rs. 0.25 crore of revenue and Rs. 0.0524 crore EBIT in the period ended March 2026, while a Jewellery Business segment that was active in earlier quarters showed no revenue in FY26. Other Income contributed Rs. 0.18 crore EBIT in the same period. The biggest expense line is other operating expenses at 17.1 percent of FY26 revenue, with employee costs at 4.4 percent and materials at 0 percent. Recent activity includes a Rs. 19.92 crore cash acquisition of a 6.37 percent stake (90.3 lakh shares at Rs. 22.06 per share) in Leapfrog Engineering Services, an EPCC firm serving oil and gas, pharma, food processing, metals and chemicals. The company also paid Rs. 2.85 crore as advance for about 49,100 sq. mtr. of land in Pune, Maharashtra, earmarked for a naturopathy centre, holistic rejuvenation centre, medicinal plant cultivation and agro-tourism.